key: cord-0860553-4jnhpn2m
authors: Polastri, Massimiliano; Daniele, Federico; Tagariello, Federico
title: Assisted mobilisation in critical patients with COVID-19
date: 2021-01-29
journal: Pulmonology
DOI: 10.1016/j.pulmoe.2021.01.004
sha: a260a23e881e5f561f312c682b0d1f155b3e9877
doc_id: 860553
cord_uid: 4jnhpn2m

The therapeutic value of early physiotherapeutic treatment in critical respiratory settings has already been clearly outlined in the last fifteen years by several authors. However, there is still a controversial perception of mobilisation by healthcare professions. In-bed cycling has attracted increasing attention having been demonstrated as a feasible and safe intervention in critical settings. Patients with respiratory diseases are typically prone to fatigue and exertional dyspnoea, as we observe in COVID-19 pandemic; in fact, these patients manifest respiratory and motor damage that can even be associated with cognitive and mental limitations. COVID-19 is at risk of becoming a chronic disease if the clinical sequelae such as pulmonary fibrosis are confirmed as permanent outcomes by further analysis, particularly in those cases with overlapping pre-existent pulmonary alterations. In the present article, we propose a practical analysis of the effects of in-bed cycling, and further discuss its potential advantages if used in critical patients with COVID-19 in intensive care settings.

The therapeutic value of early physiotherapeutic treatment in critical respiratory settings has already been clearly outlined in the last fifteen years by several authors. However, there is still a controversial perception of mobilisation by healthcare professions.

In-bed cycling has attracted increasing attention having been demonstrated as a feasible and safe intervention in critical settings. Patients with respiratory diseases are typically prone to fatigue and exertional dyspnoea, as we observe in COVID-19 pandemic; in fact, these patients manifest respiratory and motor damage that can even be associated with cognitive and mental limitations. COVID-19 is at risk of becoming a chronic disease if the clinical sequelae such as pulmonary fibrosis are confirmed as permanent outcomes by further analysis, particularly in those cases with overlapping pre-existent pulmonary alterations.

In the present article, we propose a practical analysis of the effects of in-bed cycling, and further discuss its potential advantages if used in critical patients with COVID-19 in intensive care settings. 

A 75-years-old man with a body mass index of 26.1 kg/m 2 came to our attention having several comorbidities (hypertension, dyslipidemia, bronchial asthma, ulcerative colitis, critical stenosis of both the right coronary artery and the anterior intraventricular artery treated with angioplasty and stenting) and a 40 pack/year smoking history. Before hospitalisation, his daily autonomy was limited by the reduced walking capacity resulting from an accidental fall at home requiring bed rest because of limb pain and soreness. The patient went to the emergency room given the persistence of dyspnoea, cough and fever, although therapy with antibiotics and steroids had been administered at home.

Hemogasanalysis showed moderate gas exchange impairment (PaO 2 /FiO 2 =238 mmHg and A-a O 2 gradient =50 mmHg). The chest high-resolution computed tomography demonstrated the presence of multiple large areas of peri-bronchial ground glass compatible with bilateral interstitial pneumonia ( Figure 1 ). Blood tests demonstrated elevation of phlogosis indices and associated lymphopenia: Protein-C-Reactive (8.2 mg/dL), IL-6 (160.9 pg/mL), High Ferritinemia (1098 ng/mL), Lactate dehydrogenase (461 U/L), Negative Procalcitonin (0.1 ng/mL). Given the suggestive picture, a nasal/oropharyngeal swab for SARS-Cov-2 was performed and resulted positive. This case describes a patient with severe respiratory failure in bilateral interstitial pneumonia associated with critical deterioration of the physical function because of prolonged bed rest.

The patient was initially admitted to a general ward; gas-exchanges gradually deteriorated (PaO 2 /FiO 2 =115 mmHg). He needed oxygen therapy with Ventimask and reservoir to maintain sufficient oxygenation. Given the severe deterioration, high-dose steroid therapy was also initiated. On hospital day 8, the patient was transferred to the Respiratory Intensive Care Unit (St Orsola University Hospital, Bologna, Italy) starting high flow oxygen therapy J o u r n a l P r e -p r o o f (flow 50 L/min -FiO 2 43%) because of the persistence of severe gas exchange impairment.

Given the respiratory failure, medical treatment was completed with Ruxolitinib, a selective Janus Associated Kinases inhibitor usually used for haematological diseases. 1, 2 There was a gradual improvement in gas-exchanges (PaO 2 /FiO 2 =152, 236, 278 mmHg on hospital days 18, 20, and 21, respectively), allowing suspension of oxygen therapy. Severe sarcopenia contributed to disability and reduced ability to cope with the stress of an illness, in the present case. 3

Physical evaluation revealed difficulties in getting into the sitting position on the edge of the bed autonomously; assistance was necessary to complete the postural passage from a supine to a sitting position. Marked hypotrophy of lower extremities was also present; hip flexion, knee extension, and ankle dorsiflexion were 3/5 as assessed by the Medical Research Council Muscle Scale. 4 A trial for a passage from a sitting to a standing position revealed the patient could not finalise the movement even with assistance of two operators. The patient started a physiotherapeutic programme consisting of in-bed motor exercises and specific postural transfer training, aiming to achieve sitting position as soon as possible.

Considering the clinical frame and the concomitant positivity to SARS-CoV-2, it was decided to use in-bed electrical cycle ergometry (MOTOmed letto2, RECK-Technik GmbH & Co.

KG, Betzenweiler, Germany) to facilitate and enhance lower limb function. The device is designed to provide training for both upper and lower extremities in a passive, motorassisted, and active mode directly from the hospital bed ( Figure 2) . The patient had one daily session lasting ~30 minutes, depending on clinical conditions. The exercise was supervised and was to be interrupted in the case of increased heart rate (>20 bpm from the baseline) or subjective fatigue/dyspnoea higher than moderate -scoring 3-in the modified Borg Scale. 5 J o u r n a l P r e -p r o o f Active movements of upper and lower limbs were also proposed, and the patient was asked to repeat exercises autonomously during the day while in a sitting position. The patient kept to all therapeutic sessions, and no adverse events related to treatment were observed. The patient was discharged to a low-intensity setting of care on hospital day 26, being able to maintain a sitting position and having increased lower limb mobility although not yet able to reach a standing position.

The positive effects of early mobilisation were first described in the last century when Dr Powers, in his report, illustrated that benefits occurred in a series of 100 patients undergoing different types of surgery. 6 In that study, the treatment consisted of encouraging patients to sit out of bed and to walk already on the first postoperative day, assuming such activities would bring significant advantages in enhanced recovery and restoration of daily autonomy. The study results did indeed demonstrate that all those patients treated with early mobilisation had reduced number of days in bed, length of stay and convalescence duration in weeks.

Enhanced recovery started to be discussed as early as in the 1940s; 6 nevertheless, there were no defined and specific programmes available for implementation in critical respiratory settings until the first studies were published in the mid-1990s. 7, 8 If early postoperative rehabilitation is a valuable intervention, from that study it can be gathered that a structured rehabilitation programme is feasible, safe, and effective to counteract the physical impairment and to restore functional ability in those patients who are prone to deconditioning related to respiratory failure. 8 It should be highlighted that the main differences between postoperative rehabilitation and pulmonary rehabilitation are primarily associated with the presence of the underlying respiratory disease, which poses several challenges in terms of medical and rehabilitative issues and hospital readmission rates. 9 At the same time, it should J o u r n a l P r e -p r o o f not be forgotten that pulmonary rehabilitation is a multidisciplinary intervention involving several medical professionals to manage all the clinical aspects connected to respiratoryrelated physical and psychological limitations. 10, 11 The therapeutic value of early physiotherapeutic treatment in critical respiratory settings has already been clearly outlined in the last fifteen years by several authors; [12] [13] [14] [15] [16] [17] [18] despite this, there is still a controversial perception about mobilisation by healthcare professions. 19

We used in-bed cycling; to date, no studies have researched the physiological effects of this type of assisted mobilisation in patients with COVID-19. However, in-bed cycling has attracted increasing attention, having been demonstrated as a feasible and safe intervention in critical settings. 20 To retrieve evidence regarding the use of in-bed cycling we searched PubMed and Scopus databases using the following key words "in-bed cycling", "critical patients", and "motomed letto2". Databases were searched from their inception until December 2020; we considered eligible only those citations written in English, Spanish, Italian or French. No limits were imposed for age, gender, and article types. We also searched the references of retrieved papers, and we made a further analysis of electronic search engines (i.e., Google) retrieving additional information.

Patients with respiratory diseases are typically prone to fatigue and exertional dyspnoea as we observe in COVID-19; in fact, these patients manifest respiratory and motor damages that can even be associated with cognitive and mental limitations. 21 28 Patients forced to prolonged bed rest or presenting with mobility restrictions, may simply develop muscle dysfunction or a more severe condition, namely intensive care unit acquired weakness, characterised by generalised muscle weakness affecting peripheral and respiratory muscles. 29, 30 Loss of muscle mass is negatively correlated with 2-3 weeks of immobilisation or intensive care unit stay. 31 That said, in all those conditions exposing patients to prolonged or forced restricted mobility or -even worseimmobility, primary rehabilitative goals are preserving, and hopefully, restoring a certain degree of functional capacity. COVID-19 has posed several barriers to implementing traditional physiotherapeutic activities because of the need to contain infection risk among healthcare professionals. Particularly at the beginning of the pandemic, with reduced availability of personal protective equipment, proximity with patients was conditioned by considering the risks and benefits of specific procedures, including mobilisation. A specific research line investigating characteristics and indications of personal protective equipment has contributed to improving personal protection among healthcare workers over time. [32] [33] [34] Can in-bed cycling in patients with COVID-19 be compared to treatments traditionally adopted in intensive care settings?

In a study by Ringdal and Colleagues, conducted to investigate physiological effects on inbed cycling, participants -who were patients hospitalised in an intensive setting-did not show significant and/or alarming changes in physiological parameters while exercising. Heart rate, mean arterial pressure, respiratory rate, and peripheral oxygen saturation were confined to a small range of variation, confirming in-bed cycling to be safe and feasible. 35 In the same way, participants did not manifest cardiac rhythm changes such as atrial fibrillation or ventricular tachycardia; in that study, the in-bed cycle was a suitable means for enhancing recovery and promoting motor activities in those patients who were not able to perform postural transfers. 35 Additional physiological effects were related to interrupting sedation J o u r n a l P r e -p r o o f while cycling, allowing patients to be aware of their physical activity. Other aspects of in-bed cycling executed in critical settings are related to the patient's perception of a feeling of control, safety, and hope of recovery during a critical illness. 35 Several studies have shown that in-bed cycling enhances physical function, helping to prevent muscle atrophy, and it is a feasible intervention to get patients accustomed to exercise and mobility (Table 1 ).

In addition, in-bed cycling has been found to improve consciousness and perception of personal mobility potential, emphasising another important aspect related to the hospital stay in critical settings where patients are often subjected to sedation and mechanical ventilation. 21, 41 

In RT300-SUPINE (https://www.cyclonemobility.com/product/rt300-supine-2; Cyclone Mobility, Widnes, UK) is another cycle ergometer that incorporates functional electrical stimulation using adhesive pads. The device is mounted on an expandable wheeled table and provides arm and leg cycling; adjustable housings are present for optimising arm and leg exercise, while a dedicated system controls the legs' lateral movements during cycling. The use of the RT300-SUPINE has been described in the study by Kho and Colleague. 44 The THERA-Trainer Bemo (https://thera-trainer.com/en/thera-trainer-products/cycling/theratrainer-bemo; medica Medizintechnik GmbH, Hochdorf, Germany) is another device for J o u r n a l P r e -p r o o f passive, assisted and active movements of upper and lower extremities. It is a wheeled structure that allows patients to exercise either in a supine or in a sitting position, and also provides visual feedback during the session. The device can be adjusted using the control and display unit; it includes emergency-stop functions and a system detecting spasticity.

Considering the evidence available, we gathered some common treatment schemes regarding duration, type, time, and intensity of exercise using in-bed cycling, as shown in Table 2 .

From these studies, it was possible to decide which criteria should be used for interrupting training; standard hemodynamic parameters such as heart rate, arterial pressure, and oxygen saturation should be used to guarantee safety during in-bed cycling.

In one study by Machado and Colleagues, the authors even provided the physiotherapist-topatient ratio 1:8 returning an interesting consideration on physiotherapists' workload. 40 Synthesising data from Table 2 , exercise frequency can range between 5 to 7 days a week, duration between 5 to 35 mins, with variable intensity -passive, assisted, active-depending on patients' clinical conditions.

Exercise with an in-bed cycle ergometer has been demonstrated to be feasible and safe, as outlined in several types of research. 20, 37, 43, 44 In a recent study, overall comments from patients, clinicians, and family members were positive when recalling cycling sessions; all were concordant, affirming that in-bed cycling contributed to physical recovery. 20 Among the effects of in-bed cycling, the sympathetic system stimulation has been found by Rocca and Colleagues in patients with severe neurological injury; 41 such a stimulation seems to be recognised as a mechanism leading to increased production of catecholamines. The authors concluded that in-bed cycling, in patients with subarachnoid haemorrhage, should be used with caution because of the potential risk of vasospasm due to elevated catecholamine levels. However, they did not find contraindications to its use to prevent polyneuromyopathy in critical illness. 41 In intensive care settings, in-bed cycling should be supervised to guarantee safety during exercise at all times (Table 3) .

In-bed cycle ergometry seems to be a promising intervention in different types of patients including intensive care settings, as outlined in several research studies. Although such a trend has been confirmed in published studies, up until now no clinical experiments have described the use of in-bed cycling in patients with COVID-19. Considering the knowledge and evidence gathered from literature, we feel there is enough to corroborate the hypothesis that in-bed cycling can be used in COVID settings with selected patients (i.e., respiratoryrelated motor impairment, sarcopenia, and muscle hypotrophy related to prolonged bed rest).

In addition to the therapeutic benefits for patients, in-bed cycling allows healthcare professionals to distance while operating, and this is not of secondary importance in such a pandemic. Additional advantages can be found in delegating exercise supervision to different multidisciplinary team members -once instructed-freeing specific staff -such as physiotherapists-for other simultaneous interventions, particularly when human resources are lacking or scarce.

None.

J o u r n a l P r e -p r o o f Multiple ground-glass areas (red line) with peri-bronchial distribution.

Exercise with the patient lying in a supine position (A); exercise in a sitting position with the cycle ergometer positioned laterally to the bed (B), distancing between patient and physiotherapist is possible during the exercise session (A and B).

Effects of in-bed cycling.

Authors, ref.

and year Table 2 In-bed cycling: training protocols. 20 20 cycles/min Increase in ventilatory support persisting >5 mins post-exercise, oxygen desaturation <88% for more than 1 min, increase in systolic blood pressure >180 mmHg for more than 2 min, increase in heart rate >140 bpm for more than 2 min, decrease in mean arterial blood pressure <60 mmHg, drop in heart rate <50 bpm for more than 2 min Kimawi 43 Heart rate decrease >20%, systolic blood pressure >180 mmHg, decrease >20% of systolic or diastolic blood pressure, peripheral oxygen saturation <90% Table 3 In-bed cycling: adverse events reported in the literature.

The Janus kinase

/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19

Sarcopenia and its implications for the elderly

Aids to the examination of the peripheral nervous system

Psychophysical bases of perceived exertion

The abuse of rest as a therapeutic measure in surgery: early postoperative activity and rehabilitation

Survival and prediction of successful ventilator weaning in COPD patients requiring mechanical ventilation for more than 21 days

Rehabilitation of patients admitted to a respiratory intensive care unit

Revolving door respiratory patients: A rehabilitative perspective. Monaldi Arch Chest Dis

statement: key concepts and advances in pulmonary rehabilitation

Organizational aspects of pulmonary rehabilitation in chronic respiratory diseases

Demographics and clinical outcomes of patients admitted to a respiratory intensive care unit located in a rehabilitation center

Early physiotherapy in the respiratory intensive care unit

Early activity is feasible and safe in respiratory failure patients

Receiving early mobility during an intensive care unit admission is a predictor of improved outcomes in acute respiratory failure

Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients

Rehabilitation in the intensive care unit

Physical therapy and rehabilitation in chronic obstructive pulmonary disease patients admitted to the intensive care unit

Assessment of mobilization capacity in 10 different ICU scenarios by different professions

Acceptability, safety, and feasibility of in-bed cycling with critically ill patients

Rehabilitation after critical illness in people with COVID-19 infection

Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: A narrative review

Pulmonary fibrosis in critical ill patients recovered from COVID-19 pneumonia: Preliminary experience

Converging pathways in pulmonary fibrosis and Covid-19 -The fibrotic link to disease severity

Fibrotic changes depicted by thin-section CT in patients with COVID-19 at the early recovery stage: preliminary experience

Three cases of COVID-19 pneumonia in female patients in Italy who had pulmonary fibrosis on followup lung computed tomography imaging

Post-COVID-19 pneumonia pulmonary fibrosis

Fatal pulmonary fibrosis complicating COVID-19 infection in preexistent emphysema

Clinical review: intensive care unit acquired weakness

ICU acquired weakness and recovery from critical illness

Muscle wasting in intensive care patients: ultrasound observation of the M. quadriceps femoris muscle layer

Medical masks and respirators for the protection of healthcare workers from SARAS-CoV-2 and other viruses

Protecting healthcare workers from SARS-CoV-2 infection: practical indications

COVID-19 pandemic and non invasive respiratory management: every Goliath needs a David. An evidence based evaluation of problems

Inbed cycling in the ICU; patient safety and recollections with motivational effects

Early exercise in critically ill patients enhances short-term functional recovery

Feasibility and safety of in-bed cycling for physical rehabilitation in the intensive care unit

Effect of in-bed leg cycling and electrical stimulation of the quadriceps on global muscle strength in critically ill adults: a randomized clinical trial

The effect of electrical muscle stimulation and in-bed cycling on muscle strength and mass of mechanically ventilated patients: a pilot study

Effects that passive cycling exercise have on muscle strength, duration of mechanical ventilation, and length of hospital stay in critically ill patients: a randomized clinical trial

Sympathetic activity and early mobilization in patients in intensive and intermediate care with severe brain injuries: a preliminary prospective randomized study

Critical care cycling study (CYCLIST) trial protocol: a randomised controlled trial of usual care plus additional in-bed cycling sessions versus usual care in the critically ill

Safety and feasibility of a protocolized approach to in-bed cycling exercise in the intensive care unit: quality improvement project

Multicentre pilot randomised clinical trial of early in-bed cycle ergometry with ventilated patients

Increase of the rectus femoris muscle cross-sectional area

The authors did not find significant differences regarding muscle strength between those patients who received in-bed cycling and electrical nerve stimulation and controls, as assessed by the MRC scale. Nor were differences between groups found for the following variables: 1) functional autonomy at discharge as assessed by the ICU Mobility Scale and the Katz Index of Independence in ADL, 2) number of ventilator-free days, 3) thickness of the rectus femoris Machado 40 2017 22, [general-cardiac ICU] Increase of the peripheral muscle strength as assessed by the MRC scale Rocca

At ICU discharge the following variables were higher in patients who underwent in-bed cycling: the quadriceps force (Nkg), the walked distance (6MWT), the SF-36 PF score Legend: ICU, intensive care unit; MRC

Activities of daily living; Nkg, Newtonkilogram; 6MWT, 6-minute walking test; SF-36 PF, Short Form-36 physical functioning

We would like to thank Cecilia Mari for revising the use of English in the present manuscript.

J o u r n a l P r e -p r o o f

The authors declare no conflict of interests.